Australia markets closed

MedX Health Corp (MDX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.06000.0000 (0.00%)
At close: 09:59AM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 11.02M
Enterprise value 13.50M
Trailing P/E N/A
Forward P/E 23.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.20
Price/book (mrq)N/A
Enterprise value/revenue 23.97
Enterprise value/EBITDA -3.00

Trading information

Stock price history

Beta (5Y monthly) -0.07
52-week change 3-60.00%
S&P500 52-week change 3-3.48%
52-week high 30.1600
52-week low 30.0500
50-day moving average 30.0700
200-day moving average 30.0914

Share statistics

Avg vol (3-month) 3118.94k
Avg vol (10-day) 3182.18k
Shares outstanding 5183.7M
Implied shares outstanding 6N/A
Float 8177.09M
% held by insiders 12.00%
% held by institutions 10.02%
Shares short (12 May 2022) 481.55k
Short ratio (12 May 2022) 41.84
Short % of float (12 May 2022) 4N/A
Short % of shares outstanding (12 May 2022) 40.04%
Shares short (prior month 13 Apr 2022) 424k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-810.29%

Management effectiveness

Return on assets (ttm)-389.19%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)563.1k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)10.70%
Gross profit (ttm)N/A
EBITDA -4.55M
Net income avi to common (ttm)-5.32M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)106.77k
Total cash per share (mrq)0
Total debt (mrq)2.58M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.28
Book value per share (mrq)-0.02

Cash flow statement

Operating cash flow (ttm)-4.52M
Levered free cash flow (ttm)-3.11M